Los Angeles Motor Scale e-Learning Program

A self-learning experience anytime, anywhere

Course Overview

This online self-learning program provides an introduction of the Los Angeles Motor Scale (LAMS). The purpose of this short program is to prepare the paramedics and medical first responders (MFR) for assessing stroke in the field using LAMS and understanding its implications in the transport of acute stroke patients. The launch of this program is aligned with the Alberta Health Services (AHS) pathway that is rolled out to allow acute stroke patients to access Endovascular Therapy.

Course Objectives

After completing the self-learning modules for LAMS, you will be equipped to:

  • Score LAMS when assessing a stroke patient in the field
  • Complete the AHS Stroke Screen Form
  • Pre-notify the stroke center with accurate information during patient transport
  • Apply Drip-and-Ship in various situations for patient transport
Online

Register

This online course is free for your access in our CME e-learning portal.  

Accreditation

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by University of Calgary Office of Continuing Medical Education and Professional Development. Participants may claim a maximum of 2.0 hours (credits are automatically calculated).

This Self-Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the University of Calgary Office of Continuing Medical Education and Professional Development for up to 2.0 Mainpro+ credits.

Disclosure

This program has received no commercial support.

Acknowledgement

The Acute Stroke Care e-Learning portal is provided by Quality Improvement & Clinical Research (QuICR) Alberta Stroke Program. QuICR is a partnership between Alberta Health Services, Alberta Innovates Health Solutions, University of Alberta – Faculty of Medicine and Dentistry and University of Calgary – Cumming School of Medicine.

Faculty

Disclosure:

  • Member of an Advisory Board: Pfizer/BMS, Bayer
  • Member of Speaker Bureau: Medtronic
  • Grants: Medtronic, Pfizer/BMS, Bayer, AstraZeneca; honorarium

Nothing to disclose

Nothing to disclose

Nothing to disclose

Disclosure:

  • Investments: QuikFLO Health Inc., stock ownership
  • Participation in Clinical Trial: ESCAPE, Co-investigator

Disclosure:

  • Payment from Commercial Organization: EBSCO, DynaMed Editor

Nothing to disclose

Nothing to disclose

Disclosure:

  • Grants: Allergan and Tribute, honorarium

Nothing to disclose

Nothing to disclose

Nothing to disclose

Nothing to disclose

Disclosure:

  • Member of an Advisory Board: Director of QuikFLO Health Inc. (Public Company)
  • Grants: Medtronic Ltd., for the ESCAPE trial and HERMES collaboration
  • Investments: Calgary Scientific Inc., QuikFLO Health Inc.
  • Participation in Clinical Trial: Over 40 in last 10 years

Nothing to disclose

Nothing to disclose

Nothing to disclose

Nothing to disclose

Nothing to disclose

Nothing to disclose

Disclosure:

  • Member of an Advisory Board: BMS/Pfizer, Bayer

Nothing to disclose

Nothing to disclose

Planning Committee

Disclosure:

  • Member of an Advisory Board: Director of QuikFLO Health Inc. (Public Company)
  • Grants: Medtronic Ltd., for the ESCAPE trial and HERMES collaboration
  • Investments: Calgary Scientific Inc., QuikFLO Health Inc.
  • Participation in Clinical Trial: Over 40 in last 10 years

Disclosure:

  • Payment from Commercial Organization: EBSCO, DynaMed Editor

Nothing to disclose

Disclosure:

  • Member of an Advisory Board: BMS/Pfizer, Bayer

Education Consultant, Office of Continuing Medical Education and Professional Development, Cumming School of Medicine, University of Calgary